HEADER ENDOCYTOSIS 08-JUL-24 9G0C TITLE STRUCTURE OF HUMAN MICAL1 BMERB_V978A_V985A DOMAIN:RAB10 COMPLEX. COMPND MOL_ID: 1; COMPND 2 MOLECULE: [F-ACTIN]-MONOOXYGENASE MICAL1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MOLECULE INTERACTING WITH CASL PROTEIN 1,MICAL-1,NEDD9- COMPND 5 INTERACTING PROTEIN WITH CALPONIN HOMOLOGY AND LIM DOMAINS; COMPND 6 EC: 1.14.13.225,1.6.3.1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: RAS-RELATED PROTEIN RAB-10; COMPND 11 CHAIN: B; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MICAL1, MICAL, NICAL; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: RAB10; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS MICAL, RAB GTPASE, COMPLEX, F-ACTIN, OXIDATION, ENDOCYTOSIS EXPDTA X-RAY DIFFRACTION AUTHOR A.RAI,R.S.GOODY REVDAT 1 02-JUL-25 9G0C 0 JRNL AUTH A.RAI,P.JANNING,I.R.VETTER,R.S.GOODY JRNL TITL BIOCHEMICAL AND STRUCTURAL INSIGHTS INTO THE AUTO-INHIBITED JRNL TITL 2 STATE OF MICAL1 AND ITS ACTIVATION BY RAB8 JRNL REF ELIFE 2024 JRNL REFN ESSN 2050-084X JRNL DOI 10.7554/ELIFE.102375.1 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.17.1_3660: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.22 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 37089 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.195 REMARK 3 R VALUE (WORKING SET) : 0.193 REMARK 3 FREE R VALUE : 0.231 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1854 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 41.2200 - 4.2300 1.00 2814 149 0.1727 0.1855 REMARK 3 2 4.2300 - 3.3600 1.00 2764 145 0.1697 0.2222 REMARK 3 3 3.3600 - 2.9300 1.00 2741 144 0.2011 0.2676 REMARK 3 4 2.9300 - 2.6700 1.00 2694 142 0.2096 0.2755 REMARK 3 5 2.6700 - 2.4800 1.00 2741 144 0.2134 0.2252 REMARK 3 6 2.4800 - 2.3300 1.00 2700 142 0.2134 0.2091 REMARK 3 7 2.3300 - 2.2100 1.00 2708 142 0.1990 0.2500 REMARK 3 8 2.2100 - 2.1200 0.99 2688 142 0.1976 0.2350 REMARK 3 9 2.1200 - 2.0300 0.99 2720 144 0.2054 0.2892 REMARK 3 10 2.0300 - 1.9600 0.99 2652 140 0.2229 0.2685 REMARK 3 11 1.9600 - 1.9000 0.98 2663 139 0.2442 0.3563 REMARK 3 12 1.9000 - 1.8500 0.98 2659 140 0.2822 0.3234 REMARK 3 13 1.8500 - 1.8000 0.99 2691 141 0.3356 0.3435 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.260 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 26.830 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 2630 REMARK 3 ANGLE : 0.828 3534 REMARK 3 CHIRALITY : 0.046 393 REMARK 3 PLANARITY : 0.004 452 REMARK 3 DIHEDRAL : 6.072 347 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): 17.3251 4.9978 10.5904 REMARK 3 T TENSOR REMARK 3 T11: 0.2368 T22: 0.1634 REMARK 3 T33: 0.2564 T12: -0.0070 REMARK 3 T13: -0.0208 T23: 0.0251 REMARK 3 L TENSOR REMARK 3 L11: 1.1143 L22: 0.3507 REMARK 3 L33: 1.4353 L12: -0.1048 REMARK 3 L13: -0.3689 L23: -0.0559 REMARK 3 S TENSOR REMARK 3 S11: 0.0292 S12: -0.0619 S13: -0.1274 REMARK 3 S21: -0.0516 S22: 0.0024 S23: 0.0046 REMARK 3 S31: 0.0964 S32: -0.1467 S33: -0.0315 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 9G0C COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 09-JUL-24. REMARK 100 THE DEPOSITION ID IS D_1292138979. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-SEP-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.999968 REMARK 200 MONOCHROMATOR : M REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 37165 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 41.220 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 6.900 REMARK 200 R MERGE (I) : 0.05100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.9300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.85 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.72700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.850 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.78 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.66 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.17 M SODIUM ACETATE, 0.085 M TRIS REMARK 280 -HCL PH 8.5, 25.5% (W/V) PEG 4000 AND 15% (V/V) GLYCEROL, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 24.28000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2680 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17540 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -22.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 915 REMARK 465 HIS A 916 REMARK 465 LEU A 1061 REMARK 465 GLY A 1062 REMARK 465 THR A 1063 REMARK 465 GLY A 1064 REMARK 465 ALA A 1065 REMARK 465 GLN A 1066 REMARK 465 GLY A 1067 REMARK 465 GLY B -1 REMARK 465 HIS B 0 REMARK 465 MET B 1 REMARK 465 ALA B 2 REMARK 465 LYS B 3 REMARK 465 LYS B 4 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 918 -35.93 71.29 REMARK 500 GLN A 959 50.75 -105.87 REMARK 500 MET B 126 57.04 -95.52 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 MET A 917 LYS A 918 -149.83 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG B 202 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 THR B 23 OG1 REMARK 620 2 THR B 41 OG1 83.0 REMARK 620 3 GNP B 201 O1G 168.5 85.9 REMARK 620 4 GNP B 201 O2B 95.3 177.8 95.8 REMARK 620 5 HOH B 302 O 87.8 93.5 90.1 85.0 REMARK 620 6 HOH B 305 O 88.2 85.5 93.7 95.9 176.0 REMARK 620 N 1 2 3 4 5 DBREF 9G0C A 918 1067 UNP Q8TDZ2 MICA1_HUMAN 918 1067 DBREF 9G0C B 1 175 UNP P61026 RAB10_HUMAN 1 175 SEQADV 9G0C GLY A 915 UNP Q8TDZ2 EXPRESSION TAG SEQADV 9G0C HIS A 916 UNP Q8TDZ2 EXPRESSION TAG SEQADV 9G0C MET A 917 UNP Q8TDZ2 EXPRESSION TAG SEQADV 9G0C ALA A 978 UNP Q8TDZ2 VAL 978 ENGINEERED MUTATION SEQADV 9G0C ALA A 985 UNP Q8TDZ2 VAL 985 ENGINEERED MUTATION SEQADV 9G0C GLY B -1 UNP P61026 EXPRESSION TAG SEQADV 9G0C HIS B 0 UNP P61026 EXPRESSION TAG SEQRES 1 A 153 GLY HIS MET LYS GLU GLU GLU MET LYS ARG PHE CYS LYS SEQRES 2 A 153 ALA GLN THR ILE GLN ARG ARG LEU ASN GLU ILE GLU ALA SEQRES 3 A 153 ALA LEU ARG GLU LEU GLU ALA GLU GLY VAL LYS LEU GLU SEQRES 4 A 153 LEU ALA LEU ARG ARG GLN SER SER SER PRO GLU GLN GLN SEQRES 5 A 153 LYS LYS LEU TRP VAL GLY GLN LEU LEU GLN LEU ALA ASP SEQRES 6 A 153 LYS LYS ASN SER LEU ALA ALA GLU GLU ALA GLU LEU MET SEQRES 7 A 153 ILE THR VAL GLN GLU LEU ASN LEU GLU GLU LYS GLN TRP SEQRES 8 A 153 GLN LEU ASP GLN GLU LEU ARG GLY TYR MET ASN ARG GLU SEQRES 9 A 153 GLU ASN LEU LYS THR ALA ALA ASP ARG GLN ALA GLU ASP SEQRES 10 A 153 GLN VAL LEU ARG LYS LEU VAL ASP LEU VAL ASN GLN ARG SEQRES 11 A 153 ASP ALA LEU ILE ARG PHE GLN GLU GLU ARG ARG LEU SER SEQRES 12 A 153 GLU LEU ALA LEU GLY THR GLY ALA GLN GLY SEQRES 1 B 177 GLY HIS MET ALA LYS LYS THR TYR ASP LEU LEU PHE LYS SEQRES 2 B 177 LEU LEU LEU ILE GLY ASP SER GLY VAL GLY LYS THR CYS SEQRES 3 B 177 VAL LEU PHE ARG PHE SER ASP ASP ALA PHE ASN THR THR SEQRES 4 B 177 PHE ILE SER THR ILE GLY ILE ASP PHE LYS ILE LYS THR SEQRES 5 B 177 VAL GLU LEU GLN GLY LYS LYS ILE LYS LEU GLN ILE TRP SEQRES 6 B 177 ASP THR ALA GLY GLN GLU ARG PHE HIS THR ILE THR THR SEQRES 7 B 177 SER TYR TYR ARG GLY ALA MET GLY ILE MET LEU VAL TYR SEQRES 8 B 177 ASP ILE THR ASN GLY LYS SER PHE GLU ASN ILE SER LYS SEQRES 9 B 177 TRP LEU ARG ASN ILE ASP GLU HIS ALA ASN GLU ASP VAL SEQRES 10 B 177 GLU ARG MET LEU LEU GLY ASN LYS CYS ASP MET ASP ASP SEQRES 11 B 177 LYS ARG VAL VAL PRO LYS GLY LYS GLY GLU GLN ILE ALA SEQRES 12 B 177 ARG GLU HIS GLY ILE ARG PHE PHE GLU THR SER ALA LYS SEQRES 13 B 177 ALA ASN ILE ASN ILE GLU LYS ALA PHE LEU THR LEU ALA SEQRES 14 B 177 GLU ASP ILE LEU ARG LYS THR PRO HET GNP B 201 32 HET MG B 202 1 HETNAM GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER HETNAM MG MAGNESIUM ION FORMUL 3 GNP C10 H17 N6 O13 P3 FORMUL 4 MG MG 2+ FORMUL 5 HOH *231(H2 O) HELIX 1 AA1 LYS A 918 GLN A 959 1 42 HELIX 2 AA2 PRO A 963 ASN A 1016 1 54 HELIX 3 AA3 GLU A 1018 LYS A 1022 5 5 HELIX 4 AA4 THR A 1023 ALA A 1060 1 38 HELIX 5 AA5 GLY B 21 ASP B 32 1 12 HELIX 6 AA6 GLN B 68 ARG B 70 5 3 HELIX 7 AA7 PHE B 71 SER B 77 1 7 HELIX 8 AA8 ASN B 93 ASN B 99 1 7 HELIX 9 AA9 ASN B 99 ALA B 111 1 13 HELIX 10 AB1 MET B 126 ARG B 130 5 5 HELIX 11 AB2 PRO B 133 GLY B 145 1 13 HELIX 12 AB3 ASN B 158 LYS B 173 1 16 SHEET 1 AA1 6 ILE B 44 LEU B 53 0 SHEET 2 AA1 6 LYS B 56 THR B 65 -1 O ILE B 58 N VAL B 51 SHEET 3 AA1 6 LEU B 8 ILE B 15 1 N LEU B 8 O LYS B 59 SHEET 4 AA1 6 GLY B 84 ASP B 90 1 O MET B 86 N LEU B 13 SHEET 5 AA1 6 GLU B 116 ASN B 122 1 O LEU B 120 N LEU B 87 SHEET 6 AA1 6 ARG B 147 GLU B 150 1 O ARG B 147 N LEU B 119 LINK OG1 THR B 23 MG MG B 202 1555 1555 2.04 LINK OG1 THR B 41 MG MG B 202 1555 1555 2.13 LINK O1G GNP B 201 MG MG B 202 1555 1555 2.13 LINK O2B GNP B 201 MG MG B 202 1555 1555 1.92 LINK MG MG B 202 O HOH B 302 1555 1555 2.26 LINK MG MG B 202 O HOH B 305 1555 1555 2.20 CRYST1 53.390 48.560 78.770 90.00 97.98 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018730 0.000000 0.002626 0.00000 SCALE2 0.000000 0.020593 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012819 0.00000 CONECT 1336 2600 CONECT 1482 2600 CONECT 2568 2569 2570 2571 2572 CONECT 2569 2568 2600 CONECT 2570 2568 CONECT 2571 2568 CONECT 2572 2568 2573 CONECT 2573 2572 2574 2575 2576 CONECT 2574 2573 CONECT 2575 2573 2600 CONECT 2576 2573 2577 CONECT 2577 2576 2578 2579 2580 CONECT 2578 2577 CONECT 2579 2577 CONECT 2580 2577 2581 CONECT 2581 2580 2582 CONECT 2582 2581 2583 2584 CONECT 2583 2582 2588 CONECT 2584 2582 2585 2586 CONECT 2585 2584 CONECT 2586 2584 2587 2588 CONECT 2587 2586 CONECT 2588 2583 2586 2589 CONECT 2589 2588 2590 2599 CONECT 2590 2589 2591 CONECT 2591 2590 2592 CONECT 2592 2591 2593 2599 CONECT 2593 2592 2594 2595 CONECT 2594 2593 CONECT 2595 2593 2596 CONECT 2596 2595 2597 2598 CONECT 2597 2596 CONECT 2598 2596 2599 CONECT 2599 2589 2592 2598 CONECT 2600 1336 1482 2569 2575 CONECT 2600 2710 2713 CONECT 2710 2600 CONECT 2713 2600 MASTER 281 0 2 12 6 0 0 6 2826 2 38 26 END